Beta-cell protection and therapy for latent autoimmune diabetes in adults.
Cernea
Simona
S
Department of Endocrinology & Diabetes, University Campus Bio-Medico, Rome, Italy.
Buzzetti
Raffaella
R
Pozzilli
Paolo
P
D000328:Adult; D017668:Age of Onset; D018834:Chaperonin 60 / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D005968:Glutamate Decarboxylase / Q000097:blood; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use*; D007330:Insulin Antibodies / Q000097:blood; D050417:Insulin-Secreting Cells / Q000187:drug effects / Q000502:physiology*; D008687:Metformin / Q000627:therapeutic use; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D045162:Thiazolidinediones / Q000627:therapeutic use
D018834:Chaperonin 60; D007004:Hypoglycemic Agents; D007328:Insulin; D007330:Insulin Antibodies; D013453:Sulfonylurea Compounds; D045162:Thiazolidinediones; D008687:Metformin; D005968:Glutamate Decarboxylase; C401141:glutamate decarboxylase 2